Evaluation of the Usefulness of Adalimumab in Patients with Psoriatic arthritis
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 17 Feb 2017
At a glance
- Drugs Adalimumab (Primary)
- Indications Psoriatic arthritis
- Focus Therapeutic Use
- 15 Feb 2017 Status changed from recruiting to active, no longer recruiting.
- 19 Feb 2015 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
- 19 Feb 2015 New trial record